Zobrazeno 1 - 5
of 5
pro vyhledávání: '"C. L. H. Brackel"'
Autor:
G Biesbroek, B Kapitein, I M Kuipers, M P Gruppen, D van Stijn, T E Peros, M van Veenendaal, M H A Jansen, C W van der Zee, M van der Kuip, E G J von Asmuth, M G Mooij, M E J den Boer, G W Landman, M A van Houten, D Schonenberg-Meinema, A M Tutu van Furth, M Boele van Hensbroek, H Scherpbier, K E van Meijgaarden, T H M Ottenhoff, S A Joosten, N Ketharanathan, M Blink, C L H Brackel, H L Zaaijer, P Hombrink, J M van den Berg, E P Buddingh, T W Kuijpers
Publikováno v:
PLoS ONE, Vol 17, Iss 11, p e0266336 (2022)
Multisystem Inflammatory Syndrome in Children (MIS-C) is a severe inflammatory disease in children related to SARS-CoV-2 with multisystem involvement including marked cardiac dysfunction and clinical symptoms that can resemble Kawasaki Disease (KD).
Externí odkaz:
https://doaj.org/article/46ab18e14c1f40b2aecfdd56277b7c15
Autor:
Biesbroek, G.1 (AUTHOR) g.biesbroek@amsterdamumc.nl, Kapitein, B.2 (AUTHOR), Kuipers, I. M.3 (AUTHOR), Gruppen, M. P.1 (AUTHOR), van Stijn, D.1 (AUTHOR), Peros, T. E.2 (AUTHOR), van Veenendaal, M.4 (AUTHOR), Jansen, M. H. A.4 (AUTHOR), van der Zee, C. W.5 (AUTHOR), van der Kuip, M.1 (AUTHOR), von Asmuth, E. G. J.6 (AUTHOR), Mooij, M. G.6 (AUTHOR), den Boer, M. E. J.7 (AUTHOR), Landman, G. W.8 (AUTHOR), van Houten, M. A.9 (AUTHOR), Schonenberg-Meinema, D.1 (AUTHOR), Tutu van Furth, A. M.1 (AUTHOR), Boele van Hensbroek, M.1 (AUTHOR), Scherpbier, H.1 (AUTHOR), van Meijgaarden, K. E.10 (AUTHOR)
Publikováno v:
PLoS ONE. 11/30/2022, Vol. 17 Issue 11, p1-9. 9p.
Publikováno v:
Analyst; 3/7/2024, Vol. 149 Issue 5, p1398-1415, 18p
Autor:
Lindhout, Johan
Publikováno v:
Critical Care (15744280); Feb2014, Vol. 11 Issue 1, p16-20, 5p
Autor:
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Care Services, Carol Mason Spicer, Bernice X. Chu, Paul A. Volberding
Since the onset of the coronavirus disease 2019 (COVID-19) pandemic in early 2020, many individuals infected with the virus that causes COVID-19, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have continued to experience lingering sym